Timothy S. Oh

Internal Medicine
251 E Huron St
Chicago, IL 60611

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Donor-derived acute myeloid leukemia after solid organ transplant: evidence for leukemic stem cell transmission.

Donor-derived acute myeloid leukemia after solid organ transplant: evidence for leukemic stem cell transmission.

Journal: Leukemia & lymphoma
Published: December 23, 2025

Clinicopathological and global methylation profiling of acute myeloid leukemia with mutations in NPM1 and clonal hematopoiesis-related genes.

Clinicopathological and global methylation profiling of acute myeloid leukemia with mutations in NPM1 and clonal hematopoiesis-related genes.

Journal: Leukemia & lymphoma
Published: April 25, 2025

Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapy.

Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapy.

Journal: Blood advances
Published: December 24, 2024

Response and outcomes of patients with IDH1/2- mutated accelerated/blast-phase myeloproliferative neoplasms.

Response and outcomes of patients with IDH1/2- mutated accelerated/blast-phase myeloproliferative neoplasms.

Journal: Blood neoplasia
Published: December 19, 2024

Evaluation of Ki-67 expression and large cell content as prognostic markers in MZL: a multicenter cohort study.

Evaluation of Ki-67 expression and large cell content as prognostic markers in MZL: a multicenter cohort study.

Journal: Blood cancer journal
Published: July 30, 2024

Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era.

Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era.

Journal: Blood advances
Published: February 06, 2024

Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study.

Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study.

Journal: Blood advances
Published: July 24, 2023

Outcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: a multicenter, retrospective study.

Outcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: a multicenter, retrospective study.

Journal: Haematologica
Published: April 07, 2023

Impact of detectable monoclonal protein at diagnosis on outcomes in marginal zone lymphoma: a multicenter cohort study.

Impact of detectable monoclonal protein at diagnosis on outcomes in marginal zone lymphoma: a multicenter cohort study.

Journal: Blood advances
Published: March 06, 2023

Impact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study.

Impact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study.

Journal: Journal of hematology & oncology
Published: February 26, 2023

High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study.

High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study.

Journal: Blood advances
Published: January 11, 2023

Role of Biomarkers in the Management of Acute Myeloid Leukemia.

Role of Biomarkers in the Management of Acute Myeloid Leukemia.

Journal: International journal of molecular sciences
Published: September 30, 2022
Showing 1-12 of 14

Last Updated: 09/26/2026